explore -WSS

explore

author：comprehensive 2025-10-01 16:38:17 - browse：147

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： What to make of Biden’s latest efforts on cancer research

Wikipedia

WSS

Acelyrin, a rare IPO success, stumbles in its first big test

WATCH: Why do bright lights make us see spots?

The UK government moves asylum

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

White House touts steps to stem shortages of cancer treatments

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

focus

explore

focus

Dobbs anniversary: the lost opportunity of abortion as health care

WATCH: Why do bright lights make us see spots?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

In Memoriam: Notable people who died in 2023

New weight loss drugs vying to be the next Wegovy or Mounjaro

Walensky prepares to leave CDC — and Congress — behind

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Dobbs anniversary: the lost opportunity of abortion as health care

FDA approves updated Covid vaccines

hotspot

'The Exorcist' director William Friedkin dead at 87

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Long Covid needs a new name — and a new frame

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

hotspot

Wikipedia

hotspot

focus